Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Votre recherche
Pays: Italy,Ukraine,United States,Spain,Romania,Latvia,Estonia,Lithuania,Norway,Russian Federation
nct
MAJ Il y a 5 ans
Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label Extension
The objective of the current study is to investigate the safety and efficacy of BI 10773 in 2 different doses compared to Metformin or to Sitagliptin given for 78 weeks in different modalities of treatment in patients with type 2 diabetes mellitus.
Pays
Austria
,
Croatia
,
Czech Republic
,
Estonia
,
Finland
,
France
,
Germany
,
Hungary
,
Italy
,
Korea, Republic of
,
Latvia
,
Lithuania
,
Norway
,
Romania
,
Russian Federation
,
Slovakia
,
Spain
,
Sweden
,
Taiwan, Province of China
,
Ukraine
,
United States
,
Organes
Aucun
Spécialités
Aucun
Essai clos aux inclusions
Plus d'informations
1